Cover Image

Hyperuricaemia, gout and related adverse events associated with antihypertensive drugs: A real-world analysis using the FDA adverse event reporting system

Background: The role of antihypertensive drugs in inducing hyperuricaemia and gout has been a long-term concern in clinical practice. However, clinical studies regarding this issue are limited in number and have yielded inconsistent results. We comprehensively evaluated the association between vario...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xue-Feng Jiao (Author), Kunpeng Song (Author), Xueyan Jiao (Author), Hailong Li (Author), Linan Zeng (Author), Kun Zou (Author), Wei Zhang (Author), Huiqing Wang (Author), Lingli Zhang (Author)
Format:	Book
Published:	Frontiers Media S.A., 2023-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The impact of levothyroxine therapy on pregnancy and neonatal outcomes in euthyroid pregnant women with thyroid autoimmunity: A systematic review, meta-analysis and trial sequential analysis
by: Jingjing Chen, et al.
Published: (2023)

Liver injury in children: signal analysis of suspected drugs based on the food and drug administration adverse event reporting system
by: Yan Liu, et al.
Published: (2023)

Accessibility of essential anticancer medicines for children in the Sichuan Province of China
by: Zhe Chen, et al.
Published: (2022)

Availability of essential medicines, progress and regional distribution in China: a systematic review and meta-analysis
by: Miao Zhang, et al.
Published: (2023)

The price and affordability of essential medicines, progress and regional distribution in China: a systematic review
by: Zheng Liu, et al.
Published: (2023)

Research on prescribing cascades: a scoping review
by: Zhe Chen, et al.
Published: (2023)

Hepatitis B Infection Among Pregnant Women in China: A Systematic Review and Meta-Analysis
by: Dan Liu, et al.
Published: (2022)

Long-term economic evaluation of the recombinant Mycobacterium tuberculosis fusion protein (EC) test for the diagnosis of Mycobacterium tuberculosis infection
by: Sha Diao, et al.
Published: (2023)

Tools for Identifying Potentially Inappropriate Prescriptions for Children and Their Applicability in Clinical Practices: A Systematic Review
by: Siyu Li, et al.
Published: (2022)

Accessibility of Medicines for Children: A Systematic Review
by: Zhe Chen, et al.
Published: (2021)

A tool for screening potentially inappropriate prescribing in Chinese children
by: Siyu Li, et al.
Published: (2022)

Assessment of antibiotic consumption patterns in hospital and primary healthcare using WHO Access, Watch and Reserve classification (AWaRe) in Sichuan Western China: 2020
by: Haoxin Song, et al.
Published: (2024)

Global, regional and national availability of essential medicines for children, 2009-2020: a systematic review and meta-analysis
by: Yuqing Shi, et al.
Published: (2023)

Probiotics Supplementation Therapy for Pathological Neonatal Jaundice: A Systematic Review and Meta-Analysis
by: Zhe Chen, et al.
Published: (2017)

Recombinant mycobacterium tuberculosis fusion protein for diagnosis of mycobacterium tuberculosis infection: a short-term economic evaluation
by: Zheng Liu, et al.
Published: (2023)

Safety of azithromycin in paediatrics: a systematic review protocol
by: Imti Choonara, et al.
Published: (2019)

Development of the Chinese preschooler dietary index: a tool to assess overall diet quality
by: Xiaoyu Wang, et al.
Published: (2022)

Pharmacist‐Led Intervention on the Inappropriate Use of Stress Ulcer Prophylaxis Pharmacotherapy in Intensive Care Units: A Systematic review
by: Peipei Xu, et al.
Published: (2021)

Developing a Core Outcome Set for the Evaluation of Antibiotic Use in Prelabor Rupture of Membranes: A Systematic Review and Semi-Structured Interview
by: Dan Liu, et al.
Published: (2022)

Accessibility of Essential Medicines for Children in Sichuan Province of China: A Cross-Sectional Study
by: Zhe Chen, et al.
Published: (2022)

Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration's adverse event reporting system databases
by: Qiaofang Liang, et al.
Published: (2024)

Access to medicines for children in China
by: Imti Choonara, et al.
Published: (2022)

A prospective analysis of optimal total weight gain ranges and trimester-specific weight gain rates for Chinese pregnant women
by: Yunhui Gong, et al.
Published: (2023)

Real-world pharmacovigilance analysis of galsulfase: a study based on the FDA adverse event reporting system (FAERS) database
by: Shangze Li, et al.
Published: (2024)

Efficacy and Safety of Midazolam Oral Solution for Sedative Hypnosis and Anti-anxiety in Children: A Systematic Review and Meta-Analysis
by: Xiao Cheng, et al.
Published: (2020)

Efficacy and safety of sugammadex for neuromuscular blockade reversal in pediatric patients: an updated meta-analysis of randomized controlled trials with trial sequential analysis
by: Bingchen Lang, et al.
Published: (2022)

Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS)
by: Ming-Tao Wen, et al.
Published: (2024)

Vonoprazan-associated infection: an analysis of the Japanese Adverse Drug Event Report and the FDA Adverse Event Reporting System
by: Mengling Ouyang, et al.
Published: (2024)

Willingness to participate in compensation insurance for adverse events following immunization and its influencing factors among residents in Zhejiang province
by: Ling-zhi SHEN, et al.
Published: (2023)

Safety and Tolerability of Lacosamide in Patients With Epilepsy: A Systematic Review and Meta-Analysis
by: Chunsong Yang, et al.
Published: (2021)

Severe cutaneous adverse reactions to drugs: A real-world pharmacovigilance study using the FDA Adverse Event Reporting System database
by: Dongxuan Li, et al.
Published: (2023)

Prevalence and factors associated with medication adherence in children with central precocious puberty: a cross-sectional study
by: Chunsong Yang, et al.
Published: (2024)

Adverse Events During Pregnancy Associated With Entecavir and Adefovir: New Insights From a Real-World Analysis of Cases Reported to FDA Adverse Event Reporting System
by: Renjun Yang, et al.
Published: (2022)

Gastrointestinal adverse events associated with semaglutide: A pharmacovigilance study based on FDA adverse event reporting system
by: Yamin Shu, et al.
Published: (2022)

Neurological adverse events associated with oxaliplatin: A pharmacovigilance analysis based on FDA adverse event reporting system
by: Xianglin Pan, et al.
Published: (2024)

Assessing real-world safety of plecanatide: a pharmacovigilance study based on the FDA adverse event reporting system
by: Zhiyuan Zhang, et al.
Published: (2024)

A physiologically based pharmacokinetic/pharmacodynamic model to determine dosage regimens and withdrawal intervals of aditoprim against Streptococcus suis
by: Kun Mi, et al.
Published: (2024)

Medication Choices in Children With Tic Disorders in Mainland China, Macao, Hong Kong, and Taiwan: Perspectives of Guardians and Physicians
by: Chunsong Yang, et al.
Published: (2022)

A real-world pharmacovigilance analysis of FDA adverse event reporting system database for upadacitinib
by: Yan Wu, et al.
Published: (2023)

A pharmacovigilance study of etoposide in the FDA adverse event reporting system (FAERS) database, what does the real world say?
by: Zhiwei Cui, et al.
Published: (2023)